» Articles » PMID: 11533201

The Pathogenicity of Human Immunodeficiency Virus (HIV) Type 1 Nef in CD4C/HIV Transgenic Mice is Abolished by Mutation of Its SH3-binding Domain, and Disease Development is Delayed in the Absence of Hck

Overview
Journal J Virol
Date 2001 Sep 5
PMID 11533201
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The human immunodeficiency virus type 1 (HIV-1) Nef protein is an important determinant of AIDS pathogenesis. We have previously reported that HIV-1 Nef is responsible for the induction of a severe AIDS-like disease in CD4C/HIV transgenic (Tg) mice. To understand the molecular mechanisms of this Nef-induced disease, we generated Tg mice expressing a mutated Nef protein in which the SH3 ligand-binding domain (P(72)XXP(75)XXP(78)) was mutated to A(72)XXA(75)XXQ(78). This mutation completely abolished the pathogenic potential of Nef, although a partial downregulation of the CD4 cell surface expression was still observed in these Tg mice. We also studied whether Hck, one of the effectors previously found to bind to this PXXP motif of Nef, was involved in disease development. Breeding of Tg mice expressing wild-type Nef on an hck(-/-) (knockout) background did not abolish any of the pathological phenotypes. However, the latency of disease development was prolonged. These data indicate that an intact PXXP domain is essential for inducing an AIDS-like disease in CD4C/HIV Tg mice and suggest that interaction of a cellular effector(s) with this domain is required for the induction of this multiorgan disease. Our findings indicate that Hck is an important, but not an essential, effector of Nef and suggest that another factor(s), yet to be identified, may be more critical for disease development.

Citing Articles

A Systematic Compilation of Human SH3 Domains: A Versatile Superfamily in Cellular Signaling.

Mehrabipour M, Kazemein Jasemi N, Dvorsky R, Ahmadian M Cells. 2023; 12(16).

PMID: 37626864 PMC: 10453029. DOI: 10.3390/cells12162054.


NEF-Induced HIV-Associated Nephropathy Through HCK/LYN Tyrosine Kinases.

Hu C, Priceputu E, Cool M, Chrobak P, Bouchard N, Forestier C Am J Pathol. 2023; 193(6):702-724.

PMID: 36868467 PMC: 10284032. DOI: 10.1016/j.ajpath.2023.02.006.


Apoptosis regulation by the tyrosine-protein kinase CSK.

Fortner A, Chera A, Tanca A, Bucur O Front Cell Dev Biol. 2022; 10:1078180.

PMID: 36578781 PMC: 9792154. DOI: 10.3389/fcell.2022.1078180.


μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Sperber H, Togarrati P, Raymond K, Bouzidi M, Gilfanova R, Gutierrez A FASEB J. 2020; 34(11):14615-14630.

PMID: 32901981 PMC: 8787083. DOI: 10.1096/fj.202001612RR.


Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Staudt R, Alvarado J, Emert-Sedlak L, Shi H, Shu S, Wales T J Biol Chem. 2020; 295(44):15158-15171.

PMID: 32862141 PMC: 7606690. DOI: 10.1074/jbc.REV120.012317.


References
1.
Alexander L, Weiskopf E, Greenough T, Gaddis N, Auerbach M, Malim M . Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol. 2001; 74(9):4361-76. PMC: 111953. DOI: 10.1128/jvi.74.9.4361-4376.2000. View

2.
Lang S, Iafrate A, Stahl-Hennig C, Kuhn E, Nisslein T, Kaup F . Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat Med. 1997; 3(8):860-5. DOI: 10.1038/nm0897-860. View

3.
Tokunaga K, Ikuta K, Adachi A, Matsuda M, Kurata T, Kojima A . The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry. Virology. 1999; 257(2):285-9. DOI: 10.1006/viro.1999.9682. View

4.
Nunn M, Marsh J . Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J Virol. 1996; 70(9):6157-61. PMC: 190639. DOI: 10.1128/JVI.70.9.6157-6161.1996. View

5.
Hanna Z, Kay D, Rebai N, Guimond A, Jothy S, Jolicoeur P . Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 1998; 95(2):163-75. DOI: 10.1016/s0092-8674(00)81748-1. View